Aqueous and ethanolic valeriana officinalis extracts change the binding of ligands to glutamate receptors

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Del Valle Mojica, Lisa M ^a   Cordero Hernández, José M ^a   González Medina, Giselle ^a   Ramos Vélez, Igmeris ^a   Berríos Cartagena, Nairimer ^a   Torres Hernández, Bianca A ^a   Ortíz, José G ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; DIZOCILPINE; FLUOROWILLARDINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; LIGAND; METABOTROPIC RECEPTOR; QUISQUALIC ACID; UNCLASSIFIED DRUG; VALERIAN; WATER;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SPECTROPHOTOMETRY; SYNAPTIC MEMBRANE;

EID: 79251570527     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2011/891819     Document Type: Article

References (40)

1. Miyasaka L. S., Atallah A. N., Soares B. G. O., Valerian for anxiety disorders Cochrane Database of Systematic Reviews 2006 4
2. Houghton P. J., The scientific basis for the reputed activity of valerian Journal of Pharmacy and Pharmacology 1999 51 5 505 512
3. Diaper A., Hindmarch I., A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults Phytotherapy Research 2004 18 10 831 836
4. Schulz V., Hnsel R., Blumenthal M., Tyler V. E., Rational Phytotherapy: A Reference Guide for Physicians and Pharmacists 2004 5th Berlin, Germany Springer
5. Santos M. S., Ferreira F., Cunha A. P., Carvalho A. P., Macedo T., An aqueous extract of valerian influences the transport of GABA in synaptosomes Planta Medica 1994 60 3 278 279
6. Santos M. S., Ferreira F., Cunha A. P., Carvalho A. P., Ribeiro C. F., Macedo T., Synaptosomal GABA release as influenced by valerian root extractinvolvement of the GABA carrier Archives Internationales de Pharmacodynamie et de Therapie 1994 327 2 220 231
7. Cavadas C., Araujo I., Cotrim M. D., Amaral T., Cunha A. P., Macedo T., Fontes Ribeiro C., In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABA(A) receptor in rat brain Arzneimittel-Forschung/Drug Research 1995 45 7 753 755
8. Ortiz J. G., Nieves-Natal J., Chavez P., Effects of Valeriana Officinalis extracts on [H]3 flunitrazepam binding, synaptosomal [H]3 GABA uptake, and hippocampal [H]3 GABA release Neurochemical Research 1999 24 11 1373 1378
9. Yuan C.-S., Mehendale S., Xiao Y., Aung H. H., Xie J.-T., Ang-Lee M. K., The gamma-aminobutyric acidergic effects of valerian and Valerenic acid on rat brainstem neuronal activity Anesthesia and Analgesia 2004 98 2 353 358
10. Neuhaus W., Trauner G., Gruber D., Oelzant S., Kieoal W., Kopp B., Noe C. R., Transport of a CABAA receptor modulator and its derivatives from Valeriana officinalis L s. I. across an in vitro cell culture model of the blood-brain barrier Planta Medica 2008 74 11 1338 1344
11. Malva J. O., Santos S., Macedo T., Neuroprotective properties of Valeriana officinalis extracts Neurotoxicity Research 2004 6 2 131 140
12. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Analytical Biochemistry 1976 72 1-2 248 254
13. Bent S., Padula A., Moore D., Patterson M., Mehling W., Valerian for sleep: a systemic review and meta-analysis American Journal of Medicine 2006 119 12 1005 1012
14. Leathwood P. D., Chauffard F., Heck E., Munoz-Box R., Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man Pharmacology Biochemistry and Behavior 1982 17 1 65 71
15. Stevinson C., Ernst E., Valerian for insomnia: a systematic review of randomized clinical trials Sleep Medicine 2000 1 2 91 99
16. Andreatini R., Sartori V. A., Seabra M. L. V., Leite J. R., Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study Phytotherapy Research 2002 16 7 650 654
17. Leuschner J., Mller J., Rudmann M., Characterisation of the central nervous depressant activity of a commercially available valerian root extract Arzneimittel-Forschung/Drug Research 1993 43 6 638 641
18. Lindahl O., Lindwall L., Double blind study of a Valerian preparation Pharmacology Biochemistry and Behavior 1989 32 4 1065 1066
19. Leathwood P. D., Chauffard F., Aqueous extract of valerian reduces latency to fall asleep in man Planta Medica 1985 2 144 148
20. Hattesohl M., Feistel B., Sievers H., Lehnfeld R., Hegger M., Winterhoff H., Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties Phytomedicine 2008 15 1-2 2 15
21. Benke D., Barberis A., Kopp S., Altmann K.-H., Schubiger M., Vogt K. E., Rudolph U., Mhler H., GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts Neuropharmacology 2009 56 1 174 181
22. Hendriks H., Bos R., Woerdenbag H. J., Koster A. S., Central nervous depressant activity of valerenic acid in the mouse Planta Medica 1985 1 28 31
23. Wasowski C., Marder M., Viola H., Medina J. H., Paladini A. C., Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABAA receptors, from Valeriana wallichii Planta Medica 2002 68 10 934 936
24. Schumacher B., Scholle S., Hlzl J., Khudeir N., Hess S., Mller C. E., Lignans isolated from Valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A1 adenosine receptors Journal of Natural Products 2002 65 10 1479 1485
25. Marder M., Viola H., Wasowski C., Fernndez S., Medina J. H., Paladini A. C., 6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS Pharmacology Biochemistry and Behavior 2003 75 3 537 545
26. Fernndez S., Wasowski C., Paladini A. C., Marder M., Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis Pharmacology Biochemistry and Behavior 2004 77 2 399 404
27. Granger R. E., Campbell E. L., Johnston G. A. R., (+)- and (-)-borneol: efficacious positive modulators of GABA action at human recombinant 1 22L GABAA receptors Biochemical Pharmacology 2005 69 7 1101 1111
28. Gao X. Q., Bjrk L., Valerenic acid derivatives and valepotriates among individuals, varieties and species of Valeriana Fitoterapia 2000 71 1 19 24
29. Navarrete A., Avula B., Choi Y.-W., Khan I. A., Chemical fingerprinting of valeriana species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection Journal of AOAC International 2006 89 1 8 15
30. Oliva I., Gonzlez-Trujano M. E., Arrieta J., Enciso-Rodrguez R., Navarrete A., Neuropharmacological profile of hydroalcohol extract of Valeriana edulis ssp. procera roots in mice Phytotherapy Research 2004 18 4 290 296
31. Circosta C., De Pasquale R., Samperi S., Pino A., Occhiuto F., Biological and analytical characterization of two extracts from Valeriana officinalis Journal of Ethnopharmacology 2007 112 2 361 367
32. Occhiuto F., Pino A., Palumbo D. R., Samperi S., De Pasquale R., Sturlese E., Circosta C., Relaxing effects of Valeriana officinalis extracts on isolated human non-pregnant uterine muscle Journal of Pharmacy and Pharmacology 2009 61 2 251 256
33. Ortiz J. G., Rassi N., Maldonado P. M., Gonzlez-Cabrera S., Ramos I., Commercial Valerian interactions with [ H3 ]flunitrazepam and [ H3 ]MK-801 binding to rat synaptic membranes Phytotherapy Research 2006 20 9 794 798
34. Chojnacka-Wjcik E., Klodzinska A., Pilc A., Glutamate receptor ligands as anxiolytics Current Opinion in Investigational Drugs 2001 2 8 1112 1119
35. Palucha A., Pilc A., Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs Pharmacology and Therapeutics 2007 115 1 116 147
36. Swanson C. J., Bures M., Johnson M. P., Linden A.-M., Monn J. A., Schoepp D. D., Metabotropic glutamate receptors as novel targets for anxiety and stress disorders Nature Reviews Drug Discovery 2005 4 2 131 144
37. Schoepp D. D., Wright R. A., Levine L. R., Gaydos B., Potter W. Z., LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress Stress 2003 6 3 189 197
38. Spooren W. P. J. M., Vassout A., Neijt H. C., Kuhn R., Gasparini F., Roux S., Porsolt R. D., Gentsch C., Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents Journal of Pharmacology and Experimental Therapeutics 2000 295 3 1267 1275
39. Valerian: product review,. http://www.consumerlab.com
40. Bos R., Woerdenbag H. J., Hendriks H., Zwaving J. H., De Smet P. A. G. M., Tittel G., Wikstrm H. V., Scheffer J. J. C., Analytical aspects of phytotherapeutic valerian preparations Phytochemical Analysis 1996 7 3 143 151